{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:01:05Z","timestamp":1774620065682,"version":"3.50.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To test the hypothesis that the angiotensin converting enzyme (ACE) genotype is associated with chronic beryllium disease (CBD) and disease severity, we studied 50 cases of CBD and compared their ACE genotype to that of two different control groups, consisting of: (1) 50 participants from a beryllium machining facility; and (2) 50 participants from a non-beryllium-associated workplace. We found no statistically significant difference in the frequency of the I or D allele or of the DD genotype among cases of CBD and either control group. The odds ratio (OR) for the CBD DD genotype as compared with the non-DD genotype was 1.58 (95% confidence interval [CI]: 0.68 to 3.66, p = 0.12) for the beryllium-exposed control group, and 1.09 (95% CI: 0.48 to 2.46, p = 0.56) for the non-beryllium\u2013exposed controls. We found an association between serum ACE activity and the ACE genotype, with DD cases having the highest median serum ACE activity (p = 0.005). We evaluated the beryllium lymphocyte proliferation test (BeLPT), bronchoalveolar lavage (BAL) cell components, chest radiography, pulmonary function test results, and exercise physiology in our CBD cases. No statistically significant associations with these disease markers were found for the CBD cases with the DD genotype. Although the difference was not statistically significant, the DD cases had a shorter median duration of exposure to beryllium before diagnosis of CBD, and tended to have a weaker response in their blood and BAL BeLPT than did the non-DD cases. These findings may indicate that the ACE genotype is important in the immune response to beryllium and in progression to beryllium disease.<\/jats:p>","DOI":"10.1164\/ajrccm.159.4.9806106","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T13:53:06Z","timestamp":1365083586000},"page":"1342-1350","source":"Crossref","is-referenced-by-count":38,"title":["Angiotensin-1 Converting Enzyme Polymorphisms in Chronic Beryllium Disease"],"prefix":"10.1093","volume":"159","author":[{"given":"LISA A.","family":"MAIER","sequence":"first","affiliation":[{"name":"Department of Medicine, National Jewish Medical and Research Center, Denver; Departments of Medicine, Cellular and Structural Biology, and Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARY V.","family":"RAYNOLDS","sequence":"additional","affiliation":[{"name":"Department of Medicine, National Jewish Medical and Research Center, Denver; Departments of Medicine, Cellular and Structural Biology, and Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAVID A.","family":"YOUNG","sequence":"additional","affiliation":[{"name":"Department of Medicine, National Jewish Medical and Research Center, Denver; Departments of Medicine, Cellular and Structural Biology, and Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ELIZABETH A.","family":"BARKER","sequence":"additional","affiliation":[{"name":"Department of Medicine, National Jewish Medical and Research Center, Denver; Departments of Medicine, Cellular and Structural Biology, and Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEE S.","family":"NEWMAN","sequence":"additional","affiliation":[{"name":"Department of Medicine, National Jewish Medical and Research Center, Denver; Departments of Medicine, Cellular and Structural Biology, and Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,4,1]]},"reference":[{"key":"2026032708541985600_B1"},{"key":"2026032708541985600_B2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/ajrccm\/148.4_Pt_1.985","article-title":"Epidemiology of beryllium sensitization and disease in nuclear workers.","volume":"148","author":"Kreiss","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708541985600_B3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q","article-title":"Machining risk of beryllium disease and sensitization with median exposures below 2 \u03bcg\/m3.","volume":"30","author":"Kreiss","year":"1996","journal-title":"Am. J. Ind. Med."},{"key":"2026032708541985600_B4","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/ajrccm\/145.5.1212","article-title":"Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.","volume":"145","author":"Newman","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708541985600_B5","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1378\/chest.109.3_Supplement.40S","article-title":"Immunology, genetics and epidemiology of beryllium disease.","volume":"109","author":"Newman","year":"1996","journal-title":"Chest"},{"key":"2026032708541985600_B6","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1164\/ajrccm\/139.6.1479","article-title":"Pathologic and immunologic alterations in early stages of beryllium disease.","volume":"139","author":"Newman","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708541985600_B7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1164\/ajrccm.150.1.8025739","article-title":"Compartmentalized immune response reflects clinical severity of beryllium disease.","volume":"150","author":"Newman","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708541985600_B8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0091-6749(91)90300-D","article-title":"Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.","volume":"88","author":"Mroz","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032708541985600_B9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DP\u03b21 glutamate 69: a genetic marker of beryllium disease.","volume":"262","author":"Richeldi","year":"1993","journal-title":"Science"},{"key":"2026032708541985600_B10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0274(199710)32:4<337::AID-AJIM3>3.0.CO;2-R","article-title":"Interaction of genetic and exposure factors in the prevalence of berylliosis.","volume":"32","author":"Richeldi","year":"1997","journal-title":"Am. J. Ind. Med."},{"key":"2026032708541985600_B11","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1378\/chest.109.3_Supplement.45S","article-title":"Genetic markers in beryllium hypersensitivity.","volume":"109","author":"Stubbs","year":"1996","journal-title":"Chest"},{"key":"2026032708541985600_B12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1164\/ajrccm\/146.1.39","article-title":"Serum angiotensin converting enzyme activity in chronic beryllium disease.","volume":"146","author":"Newman","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708541985600_B13","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1164\/ajrccm.155.6.9196114","article-title":"Observer variation and relationship of computed tomography to severity of beryllium disease.","volume":"155","author":"Daniloff","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708541985600_B14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4049\/jimmunol.158.1.518","article-title":"Beryllium induces IL-2 and IFN-\u03b3 in berylliosis.","volume":"158","author":"Tinkle","year":"1997","journal-title":"J. Immunol."},{"key":"2026032708541985600_B15","first-page":"197","article-title":"Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.","volume":"51","author":"Tiret","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"2026032708541985600_B16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.","volume":"86","author":"Rigat","year":"1990","journal-title":"J. Clin. Invest."},{"key":"2026032708541985600_B17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/thx.51.8.777","article-title":"Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis.","volume":"51","author":"Furuya","year":"1996","journal-title":"Thorax"},{"key":"2026032708541985600_B18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0140-6736(94)92268-3","article-title":"Synergistic effects of the angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction.","volume":"344","author":"Tiret","year":"1994","journal-title":"Lancet"},{"key":"2026032708541985600_B19","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0140-6736(93)92064-Z","article-title":"Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death.","volume":"342","author":"Marian","year":"1993","journal-title":"Lancet"},{"key":"2026032708541985600_B20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0140-6736(93)92061-W","article-title":"Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy.","volume":"342","author":"Raynolds","year":"1993","journal-title":"Lancet"},{"key":"2026032708541985600_B21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0091-6749(97)81044-5","article-title":"High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma.","volume":"99","author":"Benessiano","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032708541985600_B22","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/ki.1995.490","article-title":"U.K. prospective diabetes study XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM.","volume":"48","author":"Dudley","year":"1995","journal-title":"Kidney Int."},{"key":"2026032708541985600_B23","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(95)91088-3","article-title":"Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy.","volume":"345","author":"Harden","year":"1995","journal-title":"Lancet"},{"key":"2026032708541985600_B24"},{"key":"2026032708541985600_B25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1172\/JCI110142","article-title":"Effect of SQ 14255, an inhibitor of angiotensin I-converting enzyme on the granulomatous response to Schistosoma mansoni eggs in mice.","volume":"67","author":"Weinstock","year":"1981","journal-title":"J. Clin. Invest."},{"key":"2026032708541985600_B26"},{"key":"2026032708541985600_B27"},{"key":"2026032708541985600_B28","first-page":"457","article-title":"Respiratory function tests: normal values at medium altitudes and the prediction of normal results.","volume":"79","author":"Goldman","year":"1959","journal-title":"Am. Rev. Tuberc."},{"key":"2026032708541985600_B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI103402","article-title":"A standardized breath-holding technique for the clinical measurements of the diffusing capacity of the lung for carbon monoxide.","volume":"36","author":"Ogilvie","year":"1956","journal-title":"J. Clin. Invest."},{"key":"2026032708541985600_B30","first-page":"185","article-title":"Standardized single breath normal values for carbon monoxide diffusing capacity.","volume":"123","author":"Crapo","year":"1981","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708541985600_B31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1164\/ajrccm\/138.1.74","article-title":"Quantification of cells recovered by bronchoalveolar lavage: comparison of the cytocentrifuge preparations to the filter method.","volume":"138","author":"Willcox","year":"1988","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708541985600_B32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJM199503163321103","article-title":"A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease.","volume":"332","author":"Lindpaintner","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"2026032708541985600_B33","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1172\/JCI119321","article-title":"Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complication in insulin-dependent diabetes.","volume":"99","author":"Marre","year":"1997","journal-title":"J. Clin. Invest."},{"key":"2026032708541985600_B34","first-page":"329","article-title":"Serum angiotensin-converting enzyme for the diagnosis and therapeutic evaluation of sarcoidosis.","volume":"120","author":"Lieberman","year":"1979","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708541985600_B35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1164\/ajrccm\/148.2.483","article-title":"Amount of angiotensin-converting enzyme mRNA reflects the burden of granulomas in granulomatous lung disease.","volume":"148","author":"Gilbert","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708541985600_B36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1164\/ajrccm.156.1.9612011","article-title":"Polymorphisms in the angiotensin-converting enzyme (ACE) gene and sarcoidosis.","volume":"156","author":"Tomita","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708541985600_B37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1164\/ajrccm.153.2.8564143","article-title":"Polymorphism of angiotensin-converting enzyme gene in sarcoidosis.","volume":"153","author":"Arbustini","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708541985600_B38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/bj2900033","article-title":"Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes.","volume":"290","author":"Costerousse","year":"1993","journal-title":"Biochem. J."},{"key":"2026032708541985600_B39","first-page":"591","article-title":"Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.","volume":"313","author":"Parving","year":"1996","journal-title":"B.M.J."},{"key":"2026032708541985600_B40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF02715664","article-title":"The immunocytochemical detection of angiotensin-converting enzyme in alveolar macrophages from patients with sarcoidosis.","volume":"162","author":"Takada","year":"1984","journal-title":"Lung"},{"key":"2026032708541985600_B41","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1073\/pnas.76.12.6646","article-title":"Immunofluorescent localization of angiotensin converting enzyme in epitheliod and giant cells of sarcoidosis granulomas.","volume":"76","author":"Silverstein","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/159\/4\/1342\/67429679\/ajrccm_159_4_1342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/159\/4\/1342\/67429679\/ajrccm_159_4_1342.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:54:35Z","timestamp":1774616075000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/159\/4\/1342\/8530041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4,1]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1999,4,1]]},"published-print":{"date-parts":[[1999,4,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.159.4.9806106","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,4]]},"published":{"date-parts":[[1999,4,1]]}}}